{"id":291788,"date":"2020-05-22T18:15:55","date_gmt":"2020-05-22T16:15:55","guid":{"rendered":"https:\/\/www.pcnen.com\/portal\/?p=291788"},"modified":"2020-05-22T18:15:55","modified_gmt":"2020-05-22T16:15:55","slug":"studija-lijek-hidroksihlorokin-rizican-kod-covid-19","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2020\/05\/22\/studija-lijek-hidroksihlorokin-rizican-kod-covid-19\/","title":{"rendered":"Studija: Lijek hidroksihlorokin rizi\u010dan kod COVID-19"},"content":{"rendered":"<p>Lijek protiv malarije hidroksihlorokin povezan je s pove\u0107anim rizikom od smrti kod pacijenata sa COVID-19, pokazala je studija objavljena u medicinskom \u010dasopisu Lanset.<\/p>\n<p>Studija u kojoj je pra\u0107eno vi\u0161e od 96.000 ljudi hospitalizovanih zbog COVID-19, pokazala je da ljudi koji su lije\u010deni tim lijekom, ili srodnim hlorokinom, imaju ve\u0107i rizik od smrti u pore\u0111enju s onima koji nisu dobili tu terapiju, prenosi Tanjug vijest Rojtersa.<\/p>\n<p>Autori studije naveli su da ne mogu da potvrde da je uzimanje lijeka imalo ikakvog pozitivnog u\u010dinka kod bolesnika s virusom korona.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Autori studije naveli su da ne mogu da potvrde da je uzimanje lijeka imalo ikakvog pozitivnog u\u010dinka kod bolesnika s virusom korona<\/p>\n","protected":false},"author":1,"featured_media":289005,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-291788","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/291788","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=291788"}],"version-history":[{"count":1,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/291788\/revisions"}],"predecessor-version":[{"id":291789,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/291788\/revisions\/291789"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media\/289005"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=291788"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=291788"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=291788"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}